Related Experiment Videos
Study on the bioavailability of baicalin-phospholipid complex by using HPLC
1Department of Traditional Chinese Medicine, Shenyang Pharmaceutical University, Shenyang 110015, People's Republic of China.
Biomedical Chromatography : BMC
|October 27, 1999
Summary
This study developed a soy phospholipid complex of baicalin to enhance its absorption. The complex significantly increased baicalin bioavailability in rats compared to the free drug.
Area of Science:
- Pharmacokinetics and Drug Delivery
- Natural Product Chemistry
Background:
- Baicalin, a flavonoid from Scutellaria baicalensis, exhibits various pharmacological effects but suffers from poor oral bioavailability.
- Soy phospholipid complexation is a strategy to improve the absorption of poorly soluble compounds.
Purpose of the Study:
- To prepare a baicalin-soy phospholipid complex.
- To evaluate the pharmacokinetic profile of the complex in rats compared to free baicalin.
Main Methods:
- Preparation of baicalin-soy phospholipid complex.
- Development of a sensitive High-Performance Liquid Chromatography (HPLC) method for baicalin quantification in rat plasma.
- Pharmacokinetic analysis following oral administration in rats.
Main Results:
- The phospholipid complex significantly increased the peak plasma concentration (Cmax) of baicalin (0.90 µg/mL vs. 0.42 µg/mL).
- The complex exhibited a delayed Tmax (6.1 h vs. 5.3 h) and slower elimination compared to free baicalin.
- A significant increase in the Area Under the Curve (AUC) indicated enhanced overall exposure to baicalin from the complex (p < 0.01).
Conclusions:
- Soy phospholipid complexation effectively improves the oral bioavailability and pharmacokinetic profile of baicalin in rats.
- This formulation strategy holds promise for enhancing the therapeutic efficacy of baicalin.